Press Releases June 3, 2026 09:55 PM

BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase

BrightSpring Health Services Prices Secondary Offering and Announces Concurrent Share Repurchase

By Maya Rios BTSG

BrightSpring Health Services, Inc. priced a secondary offering of 15 million shares by existing stockholders, including a KKR affiliate and management, at $58.75 per share. The company is not selling any shares in this offering but plans to repurchase about 1 million shares concurrently from the sale proceeds without underwriting fees. The offering is expected to close on June 5, 2026, with Goldman Sachs as the sole book-running manager.

BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
BTSG

Key Points

  • Secondary offering involves 15 million shares sold by existing stockholders, raising approximately $881 million, with no new shares issued by the company.
  • Concurrent share repurchase of approximately 1 million shares will be executed by BrightSpring at the offering price, benefiting shareholder value.
  • Affiliates of private equity firm KKR and management are among the selling stockholders, indicating shareholder liquidity event but no dilution.
  • Sectors impacted include healthcare services, specifically home and community-based health care, and financial markets involving equity financing and share repurchases.

LOUISVILLE, Ky., June 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced the pricing of the previously announced underwritten secondary offering by certain of its stockholders (the “Selling Stockholders”), including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of management, of an aggregate of 15,000,000 shares of common stock of BrightSpring, at the public offering price of $58.75 per share. No shares are being sold by BrightSpring in the offering. The Selling Stockholders will receive all of the proceeds from this offering. The offering is expected to close on June 5, 2026, subject to customary closing conditions.

In addition, the Company has authorized, subject to the completion of the offering, the concurrent purchase from the underwriter, out of the 15,000,000 shares of common stock being sold as part of the secondary public offering, 1,026,694 shares of common stock at a price per share equal to the price per share to be paid by the underwriter to the Selling Stockholders. The underwriter will not receive any underwriting fees for the shares being repurchased by the Company. The closing of the share repurchase is conditioned on, and expected to occur simultaneously with, the closing of the offering. The offering is not conditioned upon the completion of the share repurchase.

Goldman Sachs & Co. LLC is acting as the sole book-running manager for the offering.

A shelf registration statement (including a prospectus) on Form S-3 relating to these securities was filed with the Securities and Exchange Commission on June 10, 2025 and became automatically effective upon filing. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering of these securities will be made only by means of a preliminary prospectus supplement and accompanying prospectus. Copies of the preliminary prospectus supplement and accompanying prospectus for the offering may be obtained from Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected].

Forward Looking Statements

The statements contained in this press release that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on BrightSpring’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These expectations, beliefs, and projections are expressed in good faith and BrightSpring believes there is a reasonable basis for them. However, there can be no assurance that these expectations, beliefs, and projections will result or be achieved. Actual results may differ materially from these expectations due to changes in global, regional, or local economic, business, competitive, market, regulatory, and other factors, many of which are beyond BrightSpring’s control. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in BrightSpring’s filings with the SEC under caption “Risk Factors,” including its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and subsequent other filings BrightSpring makes with the SEC from time to time. Any forward-looking statement in this press release speaks only as of the date of this release. BrightSpring undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.

Contacts

Investor Relations:
David Deuchler, CFA
Gilmartin Group LLC
[email protected]

or

Media Contact:
Leigh White
[email protected]
502.630.7412


Risks

  • Offering depends on customary closing conditions; any delays or regulatory issues could affect completion and stock price.
  • Secondary offering by insiders may signal to the market a reduction of insider holdings, potentially perceived negatively by investors.
  • Market and economic conditions, as well as regulatory and competitive factors in healthcare services, could impact future company performance and stock valuation.

More from Press Releases

Algoma Steel Releases 2025 Sustainability Report Jun 4, 2026 SOLV Energy Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares of Class A Common Stock Jun 4, 2026 NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option Jun 4, 2026 DLH Announces Filing of New Shelf Registration Statement Jun 4, 2026 FutureCorp Space Acquisition 1 Announces Pricing of $200,000,000 Initial Public Offering Jun 4, 2026